Retatrutide

Retatrutide is a next-generation research peptide designed for laboratory and scientific investigation. It is a triple agonist that targets the GLP-1 (glucagon-like peptide1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it an important compound for metabolic and obesity related research. This product is manufactured to high purity standards and is intended for research purposes only.

Researchers utilize Retatrutide in controlled laboratory settings to study metabolic signaling pathways, energy expenditure, body weight regulation, glucose homeostasis, and related physiological mechanisms.